Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 7, 151 - 152 (2001)
doi:10.1038/84579
From angiogenesis to lymphangiogenesis
Karl H. Plate1
- Department of Neuropathology Institute of Pathology FAU Erlangen-Nürnberg, Germany
e-mail: plate@rzmail.uni-erlangen.de
Abstract
Vascular endothelial growth factors are well-known angiogenic agents and targets for anti-cancer therapies. Now it appears that this signaling pathway is also involved in developmental and tumor-induced lymphangiogenesis (pages 186-191, 192-198, 199-205).
Cancer is the second most common cause of death in Western societies, responsible for approximately 563,100 deaths in the United States in 1999 (ref. 1).
To read this story in full you will need to login or make a payment (see right).
